1 Min Read
March 13 (Reuters) - Amicus Therapeutics Inc
* Morgan Stanley reports 5.0 percent passive stake in Amicus Therapeutics Inc as of March 6 - SEC filing Source: (bit.ly/2mkDpyi) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.